NCT02401828View on ClinicalTrials.gov

The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2017

Conditions
Human Immunodeficiency Virus
Interventions
DRUG

Dolutegravir

Switch from combination antiretroviral therapy to dolutegravir monotherapy

Trial Locations (1)

3000 CA

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER